NCT07431164 · ACTIVE NOT RECRUITING
Augmented Reality-Based Aromatherapy Education for Older Adults With Early-Stage Dementia in Taiwan
This trial is testing whether an augmented reality app combined with aromatherapy education helps older adults with early-stage dementia or MCI. Researchers will measure changes in neuropsychiatric symptoms, psychological well-being, cognition, and quality of life. It is a Phase NA study, meaning it is evaluating feasibility and early effectiveness of a non-drug approach rather than testing a pharmaceutical compound. The study is based in Taiwan.
You may qualify if
- Age ≥ 65 years
- AD-8 score ≥ 2, indicating suspected cognitive impairment
- Ability to communicate and complete study questionnaires
- No significant visual, hearing, or olfactory impairments
- Willingness to participate in AR-based intervention sessions
You're excluded if
- Diagnosed psychiatric disorder
- Complex chronic physical diseases
- Moderate to severe dementia
- Neuropsychiatric Inventory Questionnaire (NPI-Q) symptom score > 3
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-03-09